- Lilly (Indianapolis, IN)
- …the development of genetic medicines which includes active investments in Oligonucleotide development, nanomedicines for tissue specific targeting and other gene ... AAV and other non-viral vector delivery. We are seeking a highly motivated Scientist with an interest or experience in developing parenteral drug product through… more